Thousands of bottles of blood pressure medication are being pulled nationwide because of a manufacturing issue.

Announcing a new article publication for BIO Integration journal. Nitrofurantoin is a BCS II drug with a low solubility and dissolution rate. Therefore, the pharmaceutical applications of ...

The U.S. Food and Drug Administration has announced a nationwide recall of thousands of bottles of a commonly prescribed ...

When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug ...

Mumbai-based manufacturer Inventia Healthcare Limited recalled the prescription-only Chlorthalidone Tablets USP, 25 mg on ...

As one of the most effective strategies to overcome low solubility in active pharmaceutical ingredients (API), amorphization enhances the solubility and dissolution of drugs due to the higher ...

Issues with proper dissolution standards triggered Teva to issue a voluntary recall for two lots of its hypertension drug tablets Matzim LA. (Teva) () Teva issued a voluntary recall for two lots of ...

Controlling drug release rate and providing physical and chemical stability to the active pharmaceutical ingredient are key properties of oral solid dosage forms. Here, we demonstrate a formulation ...

More than 11,000 bottles of a popular blood pressure medication are being recalled after lab testing showed that the drug may ...

Fake news can be tricky to spot, but spotting fake drugs just got a little easier. Researchers have devised a low-cost way to help distinguish legitimate medications from counterfeit ones. The World ...